{
    "2018-01-16": [
        [
            {
                "time": "2023-10-10",
                "original_text": "How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines",
                "features": {
                    "keywords": [
                        "biotech",
                        "stock",
                        "migraines"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "3 Top Healthcare Stocks to Buy Right Now",
                "features": {
                    "keywords": [
                        "top",
                        "healthcare",
                        "stocks",
                        "buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Eli Lilly's Risks Could Be Underappreciated, Goldman Sachs Says In Downgrade",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "risks",
                        "Goldman Sachs",
                        "downgrade"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Big Pharma: Merck Zooms, Eli Lilly Lags",
                "features": {
                    "keywords": [
                        "big pharma",
                        "Merck",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}